Conclusion Pharmacokinetics study on target of toxic components with cross-reaction of periplocoside is feasible through drug monitor system of digoxin immunoreaction.

• 结果提示，可以用地高辛免疫反应临床药物监测系统对杠柳毒苷的交叉反应进行以毒性成分为目标的药物动力学研究。